EliA
Device
Phadia US Inc.
Total Payments
$60,836
Transactions
8
Doctors
1
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2022 | $40,101 | 4 | 1 |
| 2019 | $1,535 | 1 | 0 |
| 2018 | $19,200 | 3 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $60,822 | 7 | 100.0% |
| Food and Beverage | $14.32 | 1 | 0.0% |
Payments by Type
Research
$60,822
7 transactions
General
$14.32
1 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Research Grant Agreement to determine the earliest risk factors for food allergy development. Evaluate sensitization to food allergens in children with FPIAP compared to healthy controls in the cohort | Phadia US Inc. | $40,087 | 0 |
| Family Member Screening for Celiac Disease | Phadia US Inc. | $11,519 | 0 |
| Evaluation of the Phadia ImmunoCAP PR3, MPO and GBM | Phadia US Inc. | $6,912 | 0 |
| Diagnostic Performance of 2nd Generation tTG serological tests in different ethnic populations | Phadia US Inc. | $2,304 | 0 |
Top Doctors Receiving Payments for EliA
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Chapel Hill, NC | $60,822 | 7 |
| , MD | Allergy | Glastonbury, CT | $14.32 | 1 |
Ad
Manufacturing Companies
- Phadia US Inc. $60,836
Product Information
- Type Device
- Total Payments $60,836
- Total Doctors 1
- Transactions 8
About EliA
EliA is a device associated with $60,836 in payments to 1 healthcare providers, recorded across 8 transactions in the CMS Open Payments database. The primary manufacturer is Phadia US Inc..
Payment data is available from 2018 to 2022. In 2022, $40,101 was paid across 4 transactions to 1 doctors.
The most common payment nature for EliA is "Unspecified" ($60,822, 100.0% of total).
EliA is associated with 4 research studies, including "Research Grant Agreement to determine the earliest risk factors for food allergy development. Evaluate sensitization to food allergens in children with FPIAP compared to healthy controls in the cohort" ($40,087).